4

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: July 11, 2013
Period of Report: July 11, 2013
Accession Number: 0000908662-13-000255

View Document ↗ View on SEC.gov ↗